Incidencia de enfermedad pulmonar obstructiva crónica en pacientes con el virus de la inmunodeficiencia humana. Análisis post-hoc del estudio viva

Suarez Valdivia, L; Elías Hernández, T; Espinosa, N; López Cortés, L; Viciana, P; Asensio Cruz, MI; Marín Romero, S; Ortega Rivera, R; Pérez Serena, JC; Solier López, A; García Maldonado, AI; Gómez Rodríguez, B; Navarro Herrero, S; Serrano Gotarredona, MP; Benedicto Delgado, P; Ruiz Serrano de la Espada, MR; Fernández García, C; Borrego Delgado, MC; Sánchez Díaz, JM; Montero, E; Otero Candelera, R; Jara Palomares, L.
Rev. esp. patol. torac ; 31(3): 174-178, oct. 2019. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-187172

Documentos relacionados

  1. TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.
  2. Tobacco Use and Treatment of Tobacco Dependence Among People With Human Immunodeficiency Virus: A Practical Guide for Clinicians.
  3. Self- Evaluation Tool to Support Implementation of Treatment for Tobacco Use Disorder in Behavioral Health Programs.
  4. Developing Competency-Based Nursing Treatment for Persons With Tobacco Use Disorder.
  5. Multi-Polygenic Analysis of Nicotine Dependence in Individuals of European Ancestry.
  6. Tobacco treatment in the setting of lung cancer screening.
  7. The nicotine and tobacco epidemic among adolescents: new products are addicting our youth.
  8. Dual and Poly Use of Tobacco Products in a Sample of Pregnant Smokers: A Cross-sectional Study.
  9. Addressing Commercial Determinants to End High Tobacco Dependence Among Adolescents.
  10. Negative impact of smoking on lung function: comparing FEV1/FVC values in smokers and non-smokers.